Physician profile
Chad E Cox
NPI 1316044308
$1,611.45
in general payments reported to CMS, 2019-2025
20 companies · $422 in 2025
The $422 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $116 · 2021: $32.35 · 2022: $78.41 · 2023: $329 · 2024: $340 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.55 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $378.28 | 2021-2025 | Ubrelvy, Vraylar |
| Novo Nordisk INC | $265.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $196.91 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $125.39 | 2019-2025 | Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $107.33 | 2019 | |
| Pfizer INC. | $71.53 | 2019-2025 | |
| Exact Sciences Corporation | $64.33 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $59.46 | 2019-2025 | Veozah |
| Abbott Laboratories | $56.02 | 2019-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $55.23 | 2022-2025 | Shingrix, Arexvy |
| Irhythm Technologies, INC. | $53.76 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Merck Sharp & Dohme LLC | $42.22 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Sanofi-Aventis U.S. LLC | $36.48 | 2019-2023 | |
| Insulet Corporation | $15.92 | 2025 | Omnipod |
| Janssen Pharmaceuticals, INC | $15.24 | 2023 | Spravato |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $14.79 | 2024 | Airsupra |
| Medtronic USA, INC. | $14.61 | 2019 | |
| Amarin Pharma, INC. | $13.05 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.84 | 2019 | |
| Smith+Nephew, INC. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.